Código QR (código de barras bidimensional)

TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study

Background and ObjectivesThis study aimed to compare the efficacy of transarterial chemoembolization (TACE) plus sorafenib (TACE-S) to TACE plus lenvatinib (TACE-L) for the treatment of HCC with portal vein tumor thrombus (PVTT).MethodsThis cohort study recruited patients from September 2017 to Sept...

ver descrição completa

Na minha lista:
Principais autores: Biao Yang, Luo Jie, Ting Yang, Mingyang Chen, Yuemei Gao, Tian Zhang, Yuzu Zhang, Hao Wu, Zhengyin Liao
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021-12-01
coleção:Frontiers in Oncology
Assuntos:
hepatocellular carcinoma
lenvatinib
sorafenib
portal vein thrombosis
transcatheter arterial chemoembolization
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2021.821599/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados